Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Elisa Barbolini"'
Autor:
Ombretta Annibali, Annalisa Arcari, E. Prete, Maria Cantonetti, Francesco Merli, Mario Luppi, Vincenzo Pavone, Antonino Mulè, Piero Maria Stefani, Fulvio Massaro, G. Gini, Giuseppe Pietrantuono, Donato Mannina, Sara Galimberti, Michele Cimminiello, Agostino Tafuri, Marco Sorio, C. Patti, Potito Rosario Scalzulli, Alberto Fabbri, Andrea Rossi, Stefano Luminari, Vittorio Ruggero Zilioli, Maurizio Musso, A Pulsoni, Barbara Botto, Luigi Marcheselli, Elisa Barbolini, Andrea Visentin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf66a46f3bb3500a96db3c24b2e5e054
https://doi.org/10.1002/hon.2939/v2/response1
https://doi.org/10.1002/hon.2939/v2/response1
Autor:
Donato Mannina, Vittorio Ruggero Zilioli, Alessandro Pulsoni, Fulvio Massaro, Maurizio Musso, Elisa Barbolini, Andrea Visentin, Sara Galimberti, Antonino Mulè, Antonella Russo Rossi, Agostino Tafuri, Maria Cantonetti, Alessia Bari, Guido Gini, Luigi Marcheselli, Marco Sorio, Ombretta Annibali, Francesco Merli, Giuseppe Pietrantuono, Annalisa Arcari, E. Prete, Potito Rosario Scalzulli, Michele Cimminiello, Stefano Luminari, Vincenzo Pavone, Angelo Fabbri, Pietro Maria Stefani, Barbara Botto, C. Patti
Publikováno v:
Hematological Oncology. 39
Autor:
Sara Galimberti, Annalisa Arcari, E. Prete, Alessandro Pulsoni, Agostino Tafuri, Guido Gini, Mario Luppi, Marco Sorio, Piero Maria Stefani, Maurizio Musso, Fulvio Massaro, Luigi Marcheselli, Vincenzo Pavone, Vittorio Ruggero Zilioli, Caterina Patti, Alberto Fabbri, Stefano Luminari, Barbara Botto, Giuseppe Pietrantuono, Michele Cimminiello, Potito Rosario Scalzulli, Andrea Rossi, Maria Cantonetti, Elisa Barbolini, Andrea Visentin, Donato Mannina, Antonino Mulè, Francesco Merli, Ombretta Annibali
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT). This strategy allows almost 50% of patients to be cured. Post-ASCT maintenance treatment w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dc7d811243508742920ca647fe9cb62
http://hdl.handle.net/11577/3404956
http://hdl.handle.net/11577/3404956
Autor:
Magda Zanelli, Federica Fioroni, Marco Bertolini, Annibale Versari, Massimiliano Casali, Elisa Barbolini, Marco Lippi, Angela Ferrari, Mauro Iori, Valeria Trojani, Massimo Menga, Stefano Luminari, Francesco Merli, Stefania Gianotti, Angelo Fama
Publikováno v:
Computer Methods and Programs in Biomedicine. 185:105153
Background and objectives Malignant lymphomas are cancers of the immune system and are characterized by enlarged lymph nodes that typically spread across many different sites. Many different histological subtypes exist, whose diagnosis is typically b
Autor:
Sara Galimberti, Nicola Di Renzo, Mario Petrini, Massimo Federico, Elisa Barbolini, Carlo Visco, Caterina Stelitano, Francesco Merli, Stefano Luminari, Achille Ambrosetti, Isabella Capodanno, Fiorella Ilariucci, Francesco Caracciolo, Francesco Angrilli, Angelo Michele Carella
Publikováno v:
British Journal of Haematology. 156:346-353
Summary This study investigated the clinical activity and toxicity of R-HCVAD-AM [rituximab plus HyperCVAD (R-HCVAD) alternating with high-dose cytarabine and methotrexate (AM)] in patients with newly diagnosed Mantle Cell Lymphoma (MCL). Patients ag
Autor:
Monica Bellei, Elisa Barbolini, Antonino Maiorana, Giovanni Partesotti, Maria Angela Sirotti, Luigi Marcheselli, Goretta Bonacorsi, Caterina Mammi, Marina Cesaretti, Alessia Bari, Stefano Luminari, Ivan Rashid, Massimo Federico, Elsa Pennese, Antonella Montanini
Publikováno v:
Hematological Oncology. 25:189-197
We conducted a population-based study of peripheral lymphomas (PL) that had been diagnosed between 1997 and 2003 in the province of Modena, Italy, with the aim of providing updated incidence, clinical and survival data for these cancers. We evaluated
Autor:
Stefano Luminari, Francesco Merli, Paolo G. Gobbi, Massimo Federico, Caterina Stelitano, Donato Mannina, Matteo Dell’Olio, Maura Brugiatelli, Elisa Barbolini, Gianfranco Giglio, Giuseppe Polimeno, Luca Baldini, Alessandra Dondi
We conducted a retrospective analysis on 168 adult patients with newly diagnosed, limited-stage (I and II) diffuse large B-cell lymphoma (DLBCL) treated from 1988 to 2004 with PROMECE-CYTABOM (P-C) plus involved-field radiation therapy (IF-RT). At th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a7ceb7f90e56ff5e753a782edd5657
https://hdl.handle.net/11380/644692
https://hdl.handle.net/11380/644692
Autor:
Caterina Stelitano, Patrizio Mazza, Lorella Orsucci, Renato Scalone, Massimo Federico, Alice Di Rocco, Luigi Marcheselli, Daniele Vallisa, Elisa Barbolini, Stefano Luminari, Francesco Merli, Flavia Salvi, Luca Baldini, Maurizio Musso, Alessandra Tucci, Patrizia Pregno, Alberto Fragasso, Anna Marina Liberati, Maurizio Martelli, Fiorella Ilariucci, Chiara Bottelli
Publikováno v:
Publons
In 2003 the IIL started a randomized trial for the initial treatment of elderly patients with B-DLCL with the aim of comparing efficacy of standard R-CHOP chemotherapy vs less intensive R-miniCEOP regimen. The study was also aimed at assessing the us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::487acc52ae21ffd7fd10599aca7fb796
http://hdl.handle.net/11573/485121
http://hdl.handle.net/11573/485121
Autor:
Ferdinando Pavesi, Sara Giannini, Stefano Cassanelli, Elisa Barbolini, Piero Cravedi, Emanuele Mazzoni, Davide Bizzaro, Gian Carlo Manicardi
The wide use of insecticides containing an esteric group selected resistant Myzus persicae populations characterised by the overproduction of one of two closely related carboxylesterases (E4 and FE4). In this paper, we present data collected from Ita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1234e351d989ff8fe1189d21f253832b
https://hdl.handle.net/11380/612567
https://hdl.handle.net/11380/612567
Autor:
Elisa Barbolini, Nicola Di Renzo, Francesco Angrilli, Davide Favali, Maria Cristina Leone, Dimitriy Arioli, Fiorella Ilariucci, Carlo Visco, Francesco Merli, Stefano Luminari, Mauro Silingardi, Giovanni Bertoldero
Publikováno v:
Blood. 116:4208-4208
Abstract 4208 Introduction: Patients with lymphoma are considered at high risk of thrombosis, due to the disease itself or to the use of chemotherapy. The global risk of thrombosis is around 5%, higher in Non Hodgkin Lymphoma compared to Hodgkin Lymp